Pharmaceutical compounds and use of same in cancer and tauopathies
View Patent ↗Disclosed are compounds of formula (1)-(V): where the substituents are as provided herein. Further disclosed are methods of inhibiting tau aggregation, treating or ameliorating a tauopathy or cancer by administration of such a compound. Tau is a microtubule-binding protein that accumulates in a number of neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease (AD). The presence of abnormal tau correlates with neuron loss and memory deficits in patients with AD and other neurodegenerative disorders that involve tau accumulation.
1. A compound having a structure of formula (I):
wherein
R 1 , R 2 , and R 3 are each selected from the group consisting of hydrogen, fluoro, chloro, methoxy, methyl, or trifluoromethyl,
R 4 and R 5 are each selected from hydrogen, fluoro, and chloro,
R 6 is C 1 -C 4 alkyl or CH 2 Ar;
Ar is aryl;
R 7 is ethyl, allyl, or benzyl;
X is a pharmaceutically acceptable anion, and m is 1, 2, or 3;
with the proviso that
(1) if R 6 is alkyl, R 7 is ethyl, and each of R 4 and R 5 is hydrogen, then at least one of R 1 , R 2 , and R 3 is other than hydrogen; and
(2) when each of R 1 , R 2 , R 3 , R 4 , and R 5 is hydrogen, R 6 is CH 2 Ar.
2. A compound having a structure of formula (II):
wherein
R 1 , R 2 , and R 3 are each independently selected from the group consisting of hydrogen, chloro, fluoro, methoxy, and trifluoromethyl;
R 6 is CH 2 Ar or allyl;
Ar is aryl;
R 7 is ethyl, allyl, or benzyl; and
X is a pharmaceutically acceptable anion, and m is 1, 2, or 3.
3. A compound having a structure of formula (III):
wherein
R 1 , R 2 , and R 3 are each independently selected from the group consisting of hydrogen, chloro, fluoro, methoxy, and trifluoromethyl;
R 4 and R 5 are each selected from the group consisting of hydrogen, fluoro, and chloro;
R 7 is ethyl, allyl, or benzyl;
with the proviso that when R 7 is ethyl, at least one of R 4 and R 5 is other than hydrogen, or a salt thereof.
4. A compound having a structure selected from the group consisting of
or a compound having a structure
or a salt thereof.
5. A compound having a structure of formula (V):
wherein
Ar is pyridinyl, thiazolyl, pyrazinyl, or pyridinonyl;
R 1 , R 2 , R 3 , and R 8 are each selected from the group consisting of hydrogen, fluoro, chloro, methoxy, ethoxy, methyl, ethyl, propyl, isopropyl, trifluromethyl, SO 2 Me, NO 2 , trifluromethoxy, CN, ethoxy, propoxy, and isopropoxy, with the proviso that at least one of R 1 , R 2 , R 3 , and R 8 is not hydrogen;
R 7 is selected from ethyl, allyl, benzyl, methoxy, ethoxy, C 3-6 cycloalkyl, and (CH 2 ) 1-3 CO 2 R, and
R is a C 1-3 alkyl;
or a salt thereof.
6. A compound having the structure selected from the group consisting of
or a salt thereof.